Lipella Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Lipella Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 144% to $449,617. Profit margin reached -1027%. Total operating expenses were $2,156,734.
Profit Margin
| 2019 | 694.74K | -61.84K | -8.9% |
|---|---|---|---|
| 2020 | 961.68K | -66.45K | -6.91% |
| 2021 | 259.34K | -1.87M | -721.89% |
| 2022 | 184.15K | -2.59M | -1409.71% |
| 2023 | 449.61K | -4.61M | -1027.31% |
LIPO Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 449.61K | 184.15K | 259.34K | 961.68K | 694.74K |
Cost of revenue | 3.03M | 2.54M | 1.45M | 975.96K | 682.89K |
Gross profit | -2.58M | -2.36M | -1.19M | -14.27K | 11.85K |
Operating exp. | |||||
Research and development | 3.03M | 2.54M | 1.45M | 975.96K | 682.89K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 2.15M | 2.77M | 2.17M | 1.01M | 748.53K |
Operating income | -4.74M | -2.58M | -1.91M | -56.86K | -53.79K |
Other income (expenses), net | 126.98K | -7.97K | 50.35K | -4.79K | -8.05K |
Income before tax | -4.61M | -2.59M | -1.86M | -61.65K | -61.84K |
Income tax expense | 0 | -1.63K | 6.73K | 4.79K | -53.79K |
Net income | -4.61M | -2.59M | -1.87M | -66.45K | -61.84K |
Earnings per share | |||||
Basic EPS | -0.77 | -0.45 | -0.33 | -0.01 | -0.01 |
Diluted EPS | -0.77 | -0.45 | -0.33 | -0.01 | -0.01 |
| Data source | Data source |